AAAAAA
Results:
1-14
|
Results: 14
Authors:
Farup, PG
Hinterleitner, TA
Lukas, M
Hebuterne, X
Rachmilewitz, D
Campieri, M
Meier, R
Keller, R
Rathbone, B
Oddsson, E
Citation: Pg. Farup et al., Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis, INFLAMM B D, 7(3), 2001, pp. 237-242
Authors:
Dotan, I
Hershkoviz, R
Karmeli, F
Brazowski, E
Peled, Y
Rachmilewitz, D
Halpern, Z
Citation: I. Dotan et al., Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats, ALIM PHARM, 15(10), 2001, pp. 1687-1697
Authors:
Eliakim, R
Karmeli, F
Cohen, P
Heyman, SN
Rachmilewitz, D
Citation: R. Eliakim et al., Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats, INT J COL R, 16(1), 2001, pp. 14-21
Authors:
Eliakim, R
Karmeli, F
Rachmilewitz, D
Cohen, P
Zimran, A
Citation: R. Eliakim et al., Ozone enema - A model of microscopic colitis in rats, DIG DIS SCI, 46(11), 2001, pp. 2515-2520
Authors:
Gasche, C
Scholmerich, J
Brynskov, J
D'Haens, G
Hanauer, SB
Irvine, EJ
Jewell, DP
Rachmilewitz, D
Sachar, DB
Sandborn, WJ
Sutherland, LR
Citation: C. Gasche et al., A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998, INFLAMM B D, 6(1), 2000, pp. 8-15
Authors:
Karmeli, F
Cohen, P
Rachmilewitz, D
Citation: F. Karmeli et al., Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats, EUR J GASTR, 12(2), 2000, pp. 223-231
Authors:
Meuwissen, SGM
Ewe, K
Gassull, MA
Geboes, K
Jewell, D
Pallone, F
Rachmilewitz, D
Rask-Madsen, J
Riddell, BH
Sandborn, BJ
Schmuck, ML
Citation: Sgm. Meuwissen et al., IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine,cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases, EUR J GASTR, 12(1), 2000, pp. 13-18
Authors:
Dresner-Pollak, R
Karmeli, F
Eliakim, R
Ackerman, Z
Rachmilewitz, D
Citation: R. Dresner-pollak et al., Increased urinary N-telopeptide cross-linked type 1 collagen predicts boneloss in patients with inflammatory bowel disease, AM J GASTRO, 95(3), 2000, pp. 699-704
Authors:
Ablin, J
Shalev, O
Okon, E
Karmeli, F
Rachmilewitz, D
Citation: J. Ablin et al., Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats, INFLAMM B D, 5(4), 1999, pp. 253-261
Authors:
Eliakim, R
Karmeli, F
Cohen, P
Rachmilewitz, D
Shao, YS
Alpers, DH
Citation: R. Eliakim et al., Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle, INFLAMM B D, 5(1), 1999, pp. 16-23
Authors:
Rachmilewitz, D
Citation: D. Rachmilewitz, What comes first, the chicken or the egg? Comment, INFLAMM B D, 5(1), 1999, pp. 71-71
Authors:
Samuni, A
Karmeli, F
Moshen, M
Rachmilewitz, D
Citation: A. Samuni et al., Mechanisms underlying gastric antiulcerative activity of nitroxides in rats, FREE RAD RE, 30(2), 1999, pp. 133-140
Authors:
Rachmilewitz, D
Citation: D. Rachmilewitz, On smoking, rats, and inflammatory bowel disease, GASTROENTY, 117(4), 1999, pp. 1008-1011
Authors:
Eliakim, R
Karmeli, F
Rachmilewitz, D
Cohen, P
Fich, A
Citation: R. Eliakim et al., Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis, EUR J GASTR, 10(12), 1998, pp. 1013-1019
Risultati:
1-14
|